BDMD Stock Analysis: Buy, Sell, or Hold?
BDMD - Baird Medical Investment Holdings Ltd Ordinary Share
$0.75
0.01 (0.91%)
▲
5d:
-2.01%
30d:
-32.94%
90d:
-34.11%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Jul 29, 2026
0d
Get Alerted When BDMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: BDMD shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: BDMD shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: BDMD is currently trading at $0.75, which is considered oversold relative to its 30-day fair value range of $0.83 to $1.15. From a valuation perspective, the stock is trading at a discount (Forward PE: 5.4) compared to its historical average (7.0). Remarkably, the market is currently pricing in an annual earnings decline of 8.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, BDMD is in a strong downtrend. Immediate support is located at $0.66, while resistance sits at $1.04.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $4.00 (+432.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BDMD is in a strong downtrend. Immediate support is located at $0.66, while resistance sits at $1.04.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $4.00 (+432.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.83 -
$1.15
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 432.6% below Wall St target ($4.00)
- WARNING: Composite score 41/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.83 -
$1.15
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.66
Resistance Level
$1.04
Current Trend
Strong Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
5.36
Wall Street Target
$4.00
(+432.6%)
Revenue Growth (YoY)
24.6%
Earnings Growth (YoY)
-0.3%
Profit Margin
-64.9%
Valuation Discount vs History
-8.5% cheaper
PE vs Historical
5.4 vs 7.0
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-8.5%
(market-implied from PE analysis)
1-Year Target
$0.69
(-9%)
2-Year Target
$0.63
(-16%)
3-Year Target
$0.58
(-23%)
3-Yr Target (if PE normalizes)
(PE: 5→7)
$0.75
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.4, Growth: 75.0%)
$9.64
(+1183%)
Base:
(SPY PE: 5.4, Growth: 75.0%)
$2.53
(+238%)
Bear:
(PE: 4.6, Growth: 75.0%)
$2.15
(+187%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 5.4 to 7.0
Stabilization Target:
$0.98
(+30.5%)
PE Expansion Potential:
+30.5%
Share & Embed Analysis
Last updated: October 03, 2026 11:25 PM ET
Data refreshes hourly during market hours. Next update: 12:25 AM
Data refreshes hourly during market hours. Next update: 12:25 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BDMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$61 | 62 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$369 | 69 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 47 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 64 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 51 HOLD |